# Cherry Hill Mortgage Investment Corp: financial statements, quarterly

CHMI · NYSE · CIK 1571776 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/chmi.md) · [Financials](/companies/chmi/financials.md) · [Filings](/companies/chmi/filings.md) · [Insiders](/companies/chmi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/chmi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [(30.9) d](/filings/0001140361-26-008094.md) | [16.3](/filings/0001140361-25-017536.md) | [6.6](/filings/0001140361-25-029603.md) | [(7.1)](/filings/0001140361-25-040783.md) | [18.7 d](/filings/0001140361-26-008094.md) | [(3.1)](/filings/0001140361-26-019561.md) | [6.0](/filings/0001140361-26-032050.md) | [8.6](/filings/0001140361-26-041174.md) | [11.8 d](/filings/0001140361-26-008094.md) | [4.6](/filings/0001140361-26-019561.md) | [7.9](/filings/0001140361-26-032050.md) | [6.6](/filings/0001140361-26-041174.md) |
| Cost of revenue | $m | [3.2 d](/filings/0001140361-26-008094.md) | [2.6](/filings/0001140361-25-017536.md) | [3.5](/filings/0001140361-25-029603.md) | [3.2](/filings/0001140361-25-040783.md) | [3.1 d](/filings/0001140361-26-008094.md) | [2.5](/filings/0001140361-26-019561.md) | [2.0](/filings/0001140361-26-032050.md) | [2.3](/filings/0001140361-26-041174.md) | [2.5 d](/filings/0001140361-26-008094.md) | [2.3](/filings/0001140361-26-019561.md) | [2.3](/filings/0001140361-26-032050.md) | [2.2](/filings/0001140361-26-041174.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [13.2 d](/filings/0001140361-24-011952.md) | [13.6](/filings/0001140361-24-024544.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.7) d](/filings/0001140361-26-008094.md) | [0.7](/filings/0001140361-25-017536.md) | [0.7](/filings/0001140361-25-029603.md) | [0.3](/filings/0001140361-25-040783.md) | [2.5 d](/filings/0001140361-26-008094.md) | [0.2](/filings/0001140361-26-019561.md) | [1.1](/filings/0001140361-26-032050.md) | [0.3](/filings/0001140361-26-041174.md) | [0.6 d](/filings/0001140361-26-008094.md) | [0.9](/filings/0001140361-26-019561.md) | [0.1](/filings/0001140361-26-032050.md) | [1.6](/filings/0001140361-26-041174.md) |
| Net income | $m | [(33.6) d](/filings/0001140361-26-008094.md) | [12.1](/filings/0001140361-25-040783.md) | [0.8](/filings/0001140361-25-040783.md) | [(12.4)](/filings/0001140361-25-040783.md) | [11.8 d](/filings/0001140361-26-008094.md) | [(7.0)](/filings/0001140361-26-041174.md) | [1.6](/filings/0001140361-26-041174.md) | [4.5](/filings/0001140361-26-041174.md) | [7.9 d](/filings/0001140361-26-008094.md) | [0.4](/filings/0001140361-26-041174.md) | [3.8](/filings/0001140361-26-041174.md) | [(1.5)](/filings/0001140361-26-041174.md) |
| Diluted EPS | $ per share | not reported | [0.32](/filings/0001140361-25-017536.md) | [(0.06)](/filings/0001140361-25-029603.md) | [(0.49)](/filings/0001140361-25-040783.md) | not reported | [(0.29)](/filings/0001140361-26-019561.md) | [(0.03)](/filings/0001140361-26-032050.md) | [0.05](/filings/0001140361-26-041174.md) | not reported | [(0.05)](/filings/0001140361-26-019561.md) | [0.04](/filings/0001140361-26-032050.md) | [(0.11)](/filings/0001140361-26-041174.md) |
| Basic EPS | $ per share | not reported | [0.32](/filings/0001140361-25-017536.md) | [(0.06)](/filings/0001140361-25-029603.md) | [(0.49)](/filings/0001140361-25-040783.md) | not reported | [(0.29)](/filings/0001140361-26-019561.md) | [(0.03)](/filings/0001140361-26-032050.md) | [0.05](/filings/0001140361-26-041174.md) | not reported | [(0.05)](/filings/0001140361-26-019561.md) | [0.04](/filings/0001140361-26-032050.md) | [(0.11)](/filings/0001140361-26-041174.md) |

- Revenue: us-gaap:RevenuesNetOfInterestExpense
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [52.9](/filings/0001140361-26-008094.md) | [47.5](/filings/0001140361-25-017536.md) | [52.4](/filings/0001140361-25-029603.md) | [50.2](/filings/0001140361-25-040783.md) | [46.3](/filings/0001140361-26-008094.md) | [47.3](/filings/0001140361-26-019561.md) | [58.0](/filings/0001140361-26-032050.md) | [55.4](/filings/0001140361-26-041174.md) | [54.9](/filings/0001140361-26-041174.md) | [46.7](/filings/0001140361-26-019561.md) | [52.1](/filings/0001140361-26-032050.md) | [41.2](/filings/0001140361-26-041174.md) |
| Total assets | $m | [1,393](/filings/0001140361-25-007454.md) | [1,406](/filings/0001140361-24-024544.md) | [1,417](/filings/0001140361-24-036413.md) | [1,551](/filings/0001140361-24-046194.md) | [1,491](/filings/0001140361-26-008094.md) | [1,450](/filings/0001140361-25-017536.md) | [1,491](/filings/0001140361-25-029603.md) | [1,521](/filings/0001140361-25-040783.md) | [1,541](/filings/0001140361-26-041174.md) | [1,518](/filings/0001140361-26-019561.md) | [1,398](/filings/0001140361-26-032050.md) | [1,355](/filings/0001140361-26-041174.md) |
| Total liabilities | $m | [1,135](/filings/0001140361-25-007454.md) | [1,156](/filings/0001140361-24-024544.md) | [1,179](/filings/0001140361-24-036413.md) | [1,312](/filings/0001140361-24-046194.md) | [1,258](/filings/0001140361-26-008094.md) | [1,220](/filings/0001140361-25-017536.md) | [1,258](/filings/0001140361-25-029603.md) | [1,286](/filings/0001140361-25-040783.md) | [1,302](/filings/0001140361-26-041174.md) | [1,288](/filings/0001140361-26-019561.md) | [1,169](/filings/0001140361-26-032050.md) | [1,143](/filings/0001140361-26-041174.md) |
| Long-term debt | $m | [171](/filings/0001140361-25-007454.md) | [168](/filings/0001140361-24-024544.md) | [161](/filings/0001140361-24-036413.md) | [152](/filings/0001140361-24-046194.md) | [152](/filings/0001140361-26-008094.md) | [150](/filings/0001140361-25-017536.md) | [150](/filings/0001140361-25-029603.md) | [148](/filings/0001140361-25-040783.md) | [146](/filings/0001140361-26-041174.md) | [144](/filings/0001140361-26-019561.md) | [142](/filings/0001140361-26-032050.md) | [140](/filings/0001140361-26-041174.md) |
| Shareholders' equity | $m | [255](/filings/0001140361-25-007454.md) | [247](/filings/0001140361-24-024544.md) | [235](/filings/0001140361-24-036413.md) | [237](/filings/0001140361-24-046194.md) | [230](/filings/0001140361-26-008094.md) | [227](/filings/0001140361-25-017536.md) | [230](/filings/0001140361-25-029603.md) | [233](/filings/0001140361-25-040783.md) | [236](/filings/0001140361-26-041174.md) | [228](/filings/0001140361-26-019561.md) | [226](/filings/0001140361-26-032050.md) | [210](/filings/0001140361-26-041174.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [18.6 d](/filings/0001140361-26-008094.md) | [(19.1)](/filings/0001140361-25-017536.md) | [4.1 d](/filings/0001140361-25-029603.md) | [4.4 d](/filings/0001140361-25-040783.md) | [5.9 d](/filings/0001140361-26-008094.md) | [0.7](/filings/0001140361-26-019561.md) | [12.5 d](/filings/0001140361-26-032050.md) | [(2.4) d](/filings/0001140361-26-041174.md) | [8.4 d](/filings/0001140361-26-008094.md) | [12.6](/filings/0001140361-26-019561.md) | [4.6 d](/filings/0001140361-26-032050.md) | [17.0 d](/filings/0001140361-26-041174.md) |
| Dividends paid | $m | [0.5 d](/filings/0001140361-26-008094.md) | [6.5](/filings/0001140361-25-017536.md) | [0.3 d](/filings/0001140361-25-029603.md) | [0.3 d](/filings/0001140361-25-040783.md) | [(0.1) d](/filings/0001140361-26-008094.md) | [7.1](/filings/0001140361-26-019561.md) | [0.5 d](/filings/0001140361-26-032050.md) | [(1.7) d](/filings/0001140361-26-041174.md) | [(0.0) d](/filings/0001140361-26-008094.md) | [5.9](/filings/0001140361-26-019561.md) | [0.0 d](/filings/0001140361-26-032050.md) | [0.0 d](/filings/0001140361-26-041174.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [24.7](/filings/0001140361-24-024544.md) | [26.0](/filings/0001140361-24-036413.md) | [27.0](/filings/0001140361-24-046194.md) | [30.0](/filings/0001140361-25-017536.md) | [30.0](/filings/0001140361-25-029603.md) | [30.2](/filings/0001140361-25-040783.md) | [31.7](/filings/0001140361-26-019561.md) | [33.2](/filings/0001140361-26-032050.md) | [36.1](/filings/0001140361-26-041174.md) | [36.6](/filings/0001140361-26-019561.md) | [36.7](/filings/0001140361-26-032050.md) | [36.8](/filings/0001140361-26-041174.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 36,947,394 at 2026-10-29, from the cover of the [10-Q filed 2026-10-29](/filings/0001140361-26-041174.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:42 ET. No prices; not investment advice.